KCNJ11 and ovarian carcinoma: We demonstrate that stimulation of the Kir6.2/SUR2 activity with the pharmacological activator Minoxidil (Loniten ®) produces cell death in endometrial and ovarian cancer cells which then translates into reduced tumor growth.